XML 82 R20.htm IDEA: XBRL DOCUMENT v3.20.1
Shareholders' Deficit
3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
SHAREHOLDERS' DEFICIT
NOTE 14. SHAREHOLDERS' DEFICIT
The following table presents a reconciliation of the beginning and ending balances in Total shareholders' deficit for the three months ended March 31, 2020 (in thousands):
 
Euro Deferred Shares
 
Ordinary Shares
 
Additional Paid-in Capital
 
Accumulated Deficit
 
Accumulated Other Comprehensive Loss
 
Total Shareholders' Deficit
BALANCE, DECEMBER 31, 2019
$
45

 
$
23

 
$
8,904,692

 
$
(9,552,214
)
 
$
(219,090
)
 
$
(866,544
)
Net income

 

 

 
129,930

 

 
129,930

Other comprehensive loss

 

 

 

 
(14,437
)
 
(14,437
)
Compensation related to share-based awards

 

 
17,645

 

 

 
17,645

Tax withholding for restricted shares

 

 
(4,398
)
 

 

 
(4,398
)
Other
(1
)
 

 
(12
)
 

 

 
(13
)
BALANCE, MARCH 31, 2020
$
44

 
$
23

 
$
8,917,927

 
$
(9,422,284
)
 
$
(233,527
)
 
$
(737,817
)
The following table presents a reconciliation of the beginning and ending balances in Total shareholders' deficit for the three months ended March 31, 2019 (in thousands):
 
Euro Deferred Shares
 
Ordinary Shares
 
Additional Paid-in Capital
 
Accumulated Deficit
 
Accumulated Other Comprehensive Loss
 
Total Shareholders' Deficit
BALANCE, DECEMBER 31, 2018, PRIOR TO THE ADOPTION OF ASC 842, LEASES
$
46

 
$
22

 
$
8,855,810

 
$
(9,124,932
)
 
$
(229,229
)
 
$
(498,283
)
Effect of adopting ASC 842, Leases

 

 

 
(4,646
)
 

 
(4,646
)
BALANCE, JANUARY 1, 2019
$
46

 
$
22

 
$
8,855,810

 
$
(9,129,578
)
 
$
(229,229
)
 
$
(502,929
)
Net loss

 

 

 
(18,573
)
 

 
(18,573
)
Other comprehensive income

 

 

 

 
4,730

 
4,730

Compensation related to share-based awards

 

 
24,733

 

 

 
24,733

Exercise of options

 

 
4

 

 

 
4

Tax withholding for restricted shares

 

 
(2,414
)
 

 

 
(2,414
)
Other
(1
)
 

 

 

 

 
(1
)
BALANCE, MARCH 31, 2019
$
45

 
$
22

 
$
8,878,133

 
$
(9,148,151
)
 
$
(224,499
)
 
$
(494,450
)

Share-Based Compensation
The Company recognized share-based compensation expense of $17.6 million and $24.7 million during the three months ended March 31, 2020 and 2019, respectively. As of March 31, 2020, the total remaining unrecognized compensation cost related to non-vested share-based compensation awards amounted to $49.3 million.
As of March 31, 2020, the weighted average remaining requisite service period for non-vested stock options was 0.6 years and for non-vested restricted stock units was 1.8 years.